feline immunodeficiency virus vector-based siRNA therapy (University of Rochester)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namefeline immunodeficiency virus vector-based siRNA therapy (University of Rochester)
Drug Alias NameCOX-1/COX-2/interleukin1 receptor inhibitor (University of Rochester)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy
Mechanisms of ActionCyclooxygenase-1 inhibitorsInterleukin-1 receptor antagonistsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Interleukin-1 receptorCyclooxygenase-1
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Rochester
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Rochester
Active IndicationsN/A
Inactive IndicationsArthritis

Other Information

ATC CodeN/A
Related LinksN/A